M 321
Pill imprint M 321 has been identified as Lorazepam 0.5 mg.
Lorazepam is used in the treatment of anxiety; insomnia; nausea/vomiting; sedation; panic disorder (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy.
Lorazepam 0.5 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Lorazepam Images
- Imprint:
-
M
321 - Strength:
- 0.5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
polacrilin potassium
sodium stearyl fumarate
- Drug Class:
- Benzodiazepine anticonvulsants
Benzodiazepines
Miscellaneous antiemetics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-2321
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67544-0870 | Prepak Systems Inc (repackager) |
| 55289-0402 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Lorazepam resources
- Lorazepam
- Lorazepam (Wolters Kluwer)
- Lorazepam Solution (Wolters Kluwer)
- lorazepam (Cerner Multum)
- lorazepam injection (Cerner Multum)
- lorazepam (Micromedex) - Includes Dosage Information
- lorazepam Injection (Micromedex) - Includes Dosage Information
- Lorazepam (AHFS DI)
- Lorazepam (FDA)
- Lorazepam Concentrate (FDA)
- Lorazepam Injection (FDA)
- Lorazepam (Wolters Kluwer)


